연구동향 분석

Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol

이지은 2015년

논문상세정보
인용/피인용
' Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 부인과, 산과학, 소아과학
  • 5-anhydroglucitol
  • biological markers
  • diabetes mellitus
  • fructosamine
  • glycosylatedserumalbumin
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
671 0

0.0%

' Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol' 의 참고문헌

  • Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia
    Koga M Clin Chim Acta 412 253-257 [2011]
  • Type 1Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association
    Chiang JL Diabetes Care 37 2034-2054 [2014]
  • The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function
    Kim D Clin Endocrinol (Oxf) 77 679-683 [2012]
  • The glycation of albumin: structural and functional impacts
    Rondeau P Biochimie 93 645-658 [2011]
  • The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
    Reichard P N Engl J Med 329 304-309 [1993]
  • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    N Engl J Med 329 977-986 [1993]
  • Tests of glycemia in diabetes
    Goldstein DE Diabetes Care 27 1761-1773 [2004]
  • Tests of glycemia in diabetes
    Goldstein DE Diabetes Care 18 896-909 [1995]
  • Significance of the measurement of serum fructosamine in the management of childhood diabetes
    Shin YS Int J Pediatr Endocrinol 2013 Suppl 1 P36- [2013]
  • Serum glycated albumin as a new glycemic marker in pediatric diabetes
    이지우 Annals of Pediatirc Endocrinology & Metabolism 18 4 208-213 [2013]
  • Serum fructosamine as an index of glycaemia:comparison with glycated haemoglobin in diabetic and non-diabetic individuals
    Pandya HC Pract Diabetes Int 4 126-128 [1987]
  • Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker
    Buse JB Diabetes Technol Ther 5 355-363 [2003]
  • Serum 1,5-anhydroglucitol (1,5AG): new clinical marker for glycemic control
    Yamanouchi T Diabetes Res Clin Pract 24 Suppl S261-S268 [1994]
  • Red blood cell survival in chronic renal failure
    Ly J Am J Kidney Dis 44 715-719 [2004]
  • Prediction of nearfuture glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes
    Koga M J Diabetes Investig 2 304-309 [2011]
  • Plasma protein glycation as measured by fructosamine assay
    Mosca A Clin Chem 33 1141-1146 [1987]
  • Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients
    Yamanouchi T Diabetes 38 723-729 [1989]
  • Pitfalls in hemoglobin A1c measurement: when results may be misleading
    Radin MS. J Gen Intern Med 29 388-394 [2014]
  • Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes
    Wang PH Lancet 341 1306-1309 [1993]
  • International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes
    International Expert Committee Diabetes Care 32 1327-1334 [2009]
  • Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus
    Polgreen PM Clin Infect Dis 37 e53-e56 [2003]
  • Glycated albumin: clinical usefulness
    Koga M. Clin Chim Acta 433 96-104 [2014]
  • Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1diabetes
    Matsumoto H Intern Med 51 1315-1321 [2012]
  • Glycated albumin is lower in infants than in adults and correlated with both age and serum albumin
    Suzuki S Pediatr Diabetes 14 25-30 [2013]
  • Glycated albumin in patients with neonatal diabetes mellitus is apparently low in relation to glycemia compared with that in patients with type 1 diabetes mellitus
    Suzuki S Horm Res Paediatr 77 273-276 [2012]
  • Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus
    Suzuki S Diabetologia 54 2247-2253 [2011]
  • Evaluation of the glycated albumin/HbA1c ratio by stage of diabetic nephropathy
    Koga M Diabetol Int 2 141-145 [2011]
  • Evaluation of glycemic variability in wellcontrolled type 2 diabetes mellitus
    Chon S Diabetes Technol Ther 15 455-460 [2013]
  • Evaluation of glycated hemoglobin and fetal hemoglobin-adjusted HbA1c measurements in infants
    Suzuki S Pediatr Diabetes 14 267-272 [2013]
  • Effects of thyroid hormone on serum glycated albumin levels:study on non-diabetic subjects
    Koga M Diabetes Res Clin Pract 84 163-167 [2009]
  • Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus
    Koga M J Diabetes Complications 27 211-213 [2013]
  • Classification of variant forms of haemoglobin according to the ratio of glycated haemoglobin to glycated albumin
    Miyazaki A Ann Clin Biochem 49 Pt 5 441-444 [2012]
  • Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis
    Brown JN Pharmacotherapy 29 468-472 [2009]
  • Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay
    McGill JB Diabetes Care 27 1859-1865 [2004]
  • Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes?
    Narbonne H Diabetes Metab 27 5 Pt 1 598-603 [2001]
  • Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients
    Koga M Endocr J 53 387-391 [2006]
  • Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications
    Hirsch IB JAMA 303 2291-2292 [2010]
  • Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management
    Parrinello CM Curr Diab Rep 14 548- [2014]
  • Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose
    Juraschek SP Clin Chem 58 1648-1655 [2012]
  • Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients
    Stettler C Diabetes Care 31 1534-1535 [2008]
  • Assay of serum fructosamine that minimizes standardization and matrix problems: use to assess components of biological variation
    Howey JE Clin Chem 33 2 Pt 1 269-272 [1987]
  • Alternative markers of hyperglycemia and risk of diabetes
    Juraschek SP Diabetes Care 35 2265-2270 [2012]
  • A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group
    Imagawa A N Engl J Med 342 301-307 [2000]
  • 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes
    Dungan KM Diabetes Care 29 1214-1219 [2006]
  • 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions
    Dungan KM. Expert Rev Mol Diagn 8 9-19 [2008]
  • 1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
    석한나 Diabetes and Metabolism Journal 39 2 164-170 [2015]
  • 1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM
    Kishimoto M Diabetes Care 18 1156-1159 [1995]